title: Serotonin and cholecystokinin mediate nutrient-induced segmentation in guinea pig small intestine.
abstract: Segmentation is an important process in nutrient mixing and absorption; however, the mechanisms underlying this motility pattern are poorly understood. Segmentation can be induced by luminal perfusion of fatty acid in guinea pig small intestine in vitro and mimicked by the serotonin (5-HT) reuptake inhibitor fluoxetine (300 nM) and by cholecystokinin (CCK). Serotonergic and CCK-related mechanisms underlying nutrient-induced segmentation were investigated using selective 5-HT and CCK receptor antagonists on isolated segments of small intestine luminally perfused with 1 mM decanoic acid. Motility patterns were analyzed using video imaging and spatiotemporal maps. Segmenting activity mediated by decanoic acid was depressed following luminal application of the 5-HT receptor antagonists granisetron (5-HT(3), 1 μM) and SB-207266 (5-HT(4), 10 nM) and the CCK receptor antagonists devazepide (CCK-1, 300 nM) and L-365260 (CCK-2, 300 nM), but these antagonists did not further depress segmentation when combined. The P2 receptor antagonist pyridoxal phosphate-6-azophenyl-2',4'-disulfonate (10 μM) had no effect on activity. Serosal application of 5-HT antagonists had little effect on segmentation in the duodenum but reduced activity in the jejunum when granisetron and SB-207266 were applied together. These results reveal that 5-HT(3) and 5-HT(4) receptors, as well as CCK-1 and CCK-2 receptors, are critical in regulating decanoic acid-induced segmentation. Computational simulation indicated that these data are consistent with decanoic acid activating two pathways in the mucosa that converge within the enteric neural circuitry, while contraction-induced release of 5-HT from the mucosa provides feedback into the neural circuit to set the time course of the overall contractile activity.
authors: Department of Physiology, University of Melbourne, Parkville, Victoria, Australia. melinaellis@gmail.com
authors: Melina
authors: M
authors: Ellis
authors: Jordan D
authors: JD
authors: Chambers
authors: Rachel M
authors: RM
authors: Gwynne
authors: Joel C
authors: JC
authors: Bornstein
mesh_terms: D000818:Animals; D002766:Cholecystokinin / Q000378:metabolism*; D003652:Decanoic Acids / Q000378:metabolism; D017615:Enteric Nervous System / Q000187:drug effects / Q000502:physiology; D005227:Fatty Acids / Q000378:metabolism; D005260:Female; D005473:Fluoxetine / Q000494:pharmacology; D005769:Gastrointestinal Motility / Q000187:drug effects / Q000502:physiology*; D006168:Guinea Pigs; D007421:Intestine, Small / Q000187:drug effects / Q000502:physiology*; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects / Q000502:physiology; D016065:Myoelectric Complex, Migrating / Q000187:drug effects / Q000502:physiology; D043886:Receptor, Cholecystokinin A / Q000378:metabolism; D043887:Receptor, Cholecystokinin B / Q000378:metabolism; D058469:Receptors, Purinergic P2X / Q000378:metabolism; D044406:Receptors, Serotonin, 5-HT3 / Q000378:metabolism; D044422:Receptors, Serotonin, 5-HT4 / Q000378:metabolism; D012701:Serotonin / Q000378:metabolism*; D017367:Selective Serotonin Reuptake Inhibitors / Q000494:pharmacology
chemical_list: D002766:Cholecystokinin; D003652:Decanoic Acids; D005227:Fatty Acids; D005473:Fluoxetine; D043886:Receptor, Cholecystokinin A; D043887:Receptor, Cholecystokinin B; D058469:Receptors, Purinergic P2X; D044406:Receptors, Serotonin, 5-HT3; D044422:Receptors, Serotonin, 5-HT4; D012701:Serotonin; D017367:Selective Serotonin Reuptake Inhibitors; C031071:decanoic acid